TAVOLA ROTONDA Quale Ruolo Clinico e Quale Rimborso per la Franctional Flow Reserve? Correlazioni anatomo-funzionali FFR vs IVUS Luigi Vignali, Parma Bologna.

Slides:



Advertisements
Similar presentations
IVUS Use during Left Main PCI improve Immediate and Long Term Outcome Where is the Evidence? E Murat Tuzcu, MD, FACC Professor of Medicine Vice Chairman.
Advertisements

FFR & IVUS PRIOR TO REVASCULARISATION Journal review Dr. Sony Manuel M Senior Resident MCH Kozhikode.
FFR & IVUS PRIOR TO REVASCULARISATION Journal review Dr.Sony Manuel M Senior Resident MCH Kozhikode.
J BERLAND, SAINT-HILAIRE, ROUEN ST+: Stenting après pré-dilataion et ouverture de maille.
BIFURCATION LESIONS Dr. Tahsin.N
FRACTIONAL FLOW RESERVE versus ANGIOGRAPHY
FFR vs Angiography for Multivessel Evaluation
To stent or not to stent Clinical Utility of Fractional Flow Reserve.
29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
CORONARY PRESSURE MEASURENT AND FRACTIONAL FLOW RESERVE
DIABETES trial P Jiménez-Quevedo, M Sabaté, DJ Angiolillo, JA Gómez-Hospital, R Hernández-Antolín, J Goicolea, F Alfonso, C Bañuelos, J Escaned, R Moreno,
Complex Coronary Cases Supported by: Abbott Vascular Boston Scientific Corporation Medtronic, Inc. Astrazeneca.
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
Govt. Medical College, Calicut
Tips and Pitfalls in Measurement of FFR during Bifurcation Stenting Nanjing first hospital Nanjing cardiovascular hospital Yefei Chenshaoliang Zhangjunjie.
Multi-vessel disease and intracoronay physiology Combat MI 2009 Kees-joost Botman MD, PhD Catharina hospital Eindhoven Heart Institute The Netherlands.
Technical approach PCI in Small Vessels Washington Cardiology Center Augusto Pichard, L. Satler, K. Kent, R. Waksman, J. Laird, W. Suddath, J. Sharretts,
Jie Qian National Heart Center & FuWai Hospitall FFR in Diffuse Multivessel Disease.
When I Use IVUS Neal Uren MD FRCP Consultant Cardiologist Royal Infirmary Edinburgh.
Featuring CTO Complex-PCI by Trans-radial Approach CTO Case review 5 French TRI CTO of right coronary artery -5 F Launcher guiding Catheter (right Judkins.
SIROLIMUS-ELUTING STENTS EFFECTIVELY INHIBIT NEOINTIMAL PROLIFERATION AS COMPARED TO BARE METAL STENTS IN DISEASED SAPHENOUS VEIN GRAFTS: 6-month IVUS.
Which is the role of post-dilation after DES implantation? Enrico Romagnoli 1,2 M.D., Ph.D. 1 Policlinico Casilino, Roma 2 Opedale San Raffaele, Milano.
LM strategy Interventional cardiology dpt Cardiovascular Hospital - Lyon - France Gilles Rioufol MD PhD INSERM U1060 High Tech Marseille, 26 Janvier 2012.
左主干分叉病变治疗策略的选择 Left main bifurcation: what is the best choice? Lei Ge, MD Department of Cardiology, Zhongshan Hospital, Fudan University.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
Direct Stenting is Better (Debate Session) 동아의대 김 무 현.
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
左主干病变 PCI 中 IVUS 的指导 作用:是否必需? 钱杰阜外心血管病医院. 术前评价 LM 病变.
Treatment of bifurcation lesions is a complex problem Different techniques are commonly used (Y-/T-stenting, „culotte“ technique, „kissing stent“ technique…)
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
ISAR-CABG Objective To compare the efficacy of DES with BMS in a randomized trial powered for clinical events Sample 610 patients with de novo SVG lesions.
Saqib Chowdhary Wythenshawe Hospital STENT THROMBOSIS How Do IVUS & OCT Help.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Comprehensive Assessment of Coronary Artery Stenoses:
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prospective Application of Pre-Defined Intravascular.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Calculation From 3-Dimensional.
Columbia University Medical Center Cardiovascular Research Foundation New York City, NY Akiko Maehara, MD Use of IVUS Reduces Stent Thrombosis and Myocardial.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implantation of a Drug-Eluting Stent With a Different.
Influence of a Pressure Gradient Distal to Implanted Bare-Metal Stent on In-Stent Restenosis After Percutaneous Coronary Intervention Lisette Okkels Jensen,
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Treatment of Protected and Unprotected.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
Intravascular ultrasound (IVUS) in percutaneous coronary intervention – summary of key articles While angiography is routinely used for assessment of CAD,
Intravascular ultrasound (IVUS) in the treatment of long and diffuse lesions– summary of key articles Prepared by Radcliffe Cardiology 21 November2016.
Intravascular ultrasound (IVUS) in percutaneous coronary interventions – summary of key articles While angiography is routinely used for assessment of.
Disrupt CAD Study Design
My initial ABSORB experience Assoc. Prof. I. Petrov
Disclosure Statement of Financial Interest
FFR DECISION MAKING DURING DIAGNOSTIC PROCEDURES
Nico H.J. Pijls, William F. Fearon, Peter Jüni, and Bernard De Bruyne
IVUS, FFR, OCT- Which Should I Use For PCI?
on behalf of the ABSORB II Investigators
Clinical Usefulness of Post-Stenting FFR
(DES)+BVS +DCB for long diffuse LAD disease
When IVUS? When FFR? Assessing Intermediate Lesions
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
Overview of the Clinical Utility of IVUS to Optimize PCI
OCT-Guided PCI What needs to be done to establish criteria?
Impella 2.5® Device Is Associated with Improved Survival in AMICS
Fractional Flow Reserve Workshop
Circ Cardiovasc Interv
Long-term follow-up of the DIABETES I (DIABETes and sirolimus Eluting Stent) trial: P Jiménez-Quevedo, M Sabaté, DJ Angiolillo, JA Gómez-Hospital, R Hernández-Antolín,
Angiography-guided PCI
3-Year Clinical Outcomes From the RESOLUTE US Study
Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-year Outcomes of the EVERBIO.
Bifurcation Disease: Simulation Training Curriculum
The American College of Cardiology Presented by Dr. A. Abazid
FFR guided deferral of PCI in patients with ACS and stable coronary artery disease (SCAD). FFR guided deferral of PCI in patients with ACS and stable coronary.
Presentation transcript:

TAVOLA ROTONDA Quale Ruolo Clinico e Quale Rimborso per la Franctional Flow Reserve? Correlazioni anatomo-funzionali FFR vs IVUS Luigi Vignali, Parma Bologna 21 Aprile 2011

IVUS guidance in PCI Indications

IVUS in evaluation for Post dilatation needs Post-dilatation strategy: With non-compliant balloon shorter than stent in presence of vessel remodelling or uncompleted- apposition Pre Stent Posdil Under expansion Stent Mal apposition IVUS reveals need of postdilatation

IVUS-guided stent implantation may be considered for unprotected left main PCI CLASS IIb EVIDENCE C Recommendations for specific percutaneous coronary intervention devices

IVUS in ISR Beware that expected ISR might reveal under expanded stent during previous intervention. Because the vessel and plaque and stents became visible, IVUS guidance clarify substrate in failure or previous PCI, and frequently discover under expanded stents IVUS reveals stent underexpansion in ISR

Performance Comparison, OCT vs IVUS Spazial Resolution  m  m Acquisition Time20 mm/s mm/s Tissue Penetration mm10 mm Contrast enjection during acquisition Every imagesNo contrast IVUS C7 XR

Image Comparison 10 Edge dissection during stent implantation  Neointimal growth on previously implanted stent at follow-up ???

Validation of IVUS Assessment of Ischemia-producing Stenoses (Doppler FloWire, SPECT, and Pressure Wire) 439 CFR  CFR < 2.0 IVUS MLA <4.0mm 2 IVUS MLA  4.0mm 2 Diagnostic accuracy = 92%. Abizaid et al. Am J Cardiol 1998;82: Spect Spect IVUS MLA <4.0mm 2 IVUS MLA  4.0mm 2 Diagnostic accuracy = 93%. Nishioka et al. J Am Coll Cardiol 1999;33: Takagi, et al. Circulation 1999;100:250-5

IVUS in intermediate assessment Proximal LAD, CX, RCA Takagi, et al. Circulation 1999;100:250-5 Intermediate stenosis assessment: If in Proximal LAD, CC or RCA, the stenosis MLA ≤ 4 mm 2 then is cause isquemia; and must be treated IVUS reveals significance of intermediate lesions, with morphological assessment

Clinical follow-up in 357 Intermediate Lesions in 300 Pts with Deferred Intervention after IVUS Imaging (mean) 13 mos = 8% overall (2% death/MI and 6% TLR) (mean) 13 mos = 8% overall (2% death/MI and 6% TLR) (mean) 13 mos = 4.4% in lesions with MLA >4.0mm 2 (mean) 13 mos = 4.4% in lesions with MLA >4.0mm 2 Only independent predictor of death/MI/TLR was IVUS MLA (p=0.0041) Only independent predictor of death/MI/TLR was IVUS MLA (p=0.0041) Independent predictors of TLR were DM (p=0.0493) and IVUS MLA (p=0.0042) Independent predictors of TLR were DM (p=0.0493) and IVUS MLA (p=0.0042) IVUS MLD (mm) QCA MLD (mm) r=0.339 IVUS MLA (mm 2 ) Death/MI/TLR 5555 IVUS MLA (mm 2 ) TLR DM no-DM 5555 Abizaid et al. Circulation 1999;100:256-61

Confidential information of Boston Scientific Corporation. Do not copy or distribute. In Intermediate stenosis assessment: Event Free Survival is better for the IVUS Criteria vs. the FFR >0.75 Criteria.

Follow-up of 122 patients with moderate LEFT MAIN disease Indipendent predictors of Months:DM (p=0.004) and IVUS MLD (p=0.005)- but NOT the palque burden Abizaid, et al. J Am Coll Cardiol 1999;34:

Intermediate Main Left stenosis assessment: If Main Left MLA ≤ 6 mm 2 cause isquemia and must be treated IVUS in intermediate assessment in Left Main IVUS assess significance of Main Left lesions, where angio fails

IVUS determinants of LMCA FFR<0.75 Jasti et al Circulation 2004; 110;2831-6

Months Cumulative proportion surviving Logrank test: p = 0.04 REV 93.4% DEF 98.1% Kaplan-Meier survival free from mortality and infarction 331 Patients 179 pt MLA>6 mm 2 (DEF group) 152 pt MLA<6 mm 2 (REV group) PCI 44% CABG 55% MULTICENTERDED LITRO STUDY INTERMEDIATE LEFT MAIN CORONARY ARTERY LESION Jose’ M de la torre Hernandez et al.JACC 2010;vol55

Absolute lumen CSA <5.9 mm 2 (or MLD < 2.8 mm) is the suggested criterion for significant LMCA stenosis IVUS Criteria for a “significant” LMCA stenosis

FFR= 0,70 LA= 5,5 LA= 4,5 LA= 8,0

Chang-Wook Nam et al 2010;JACC interventions vol 3 :812-7 FFR vs IVUS in Intermediate Coronary Lesions 167 consecutive patients FFR guided IVUS guided 91.5% 33,7% The rate of performing PCI according to guiding device Time to event (days) Event Free Survaival (%) P>0.05 Cutoff value FFR 0.80 Cutoff value IVUS MLA >4mm2 (FFR-guided,83 lesion vs IVUS-guided,94 lesion)

CORRELATION BETWEEN FFR AND IVUS LUMEN AREA IN 150 INTERMEDIATE CORONARY STENOSIS Itsik Ben-Dior, Ron Waksman et al 2011.JACC For lesion with vessel reference diameters of mm, mm and >3.5 mm, the MLA threshold for FFR <0.8 were 2.5,2.8 and 3.7 mm 2 respectively

FFR= 0,74

COMPLEMENTARY ROLE IVUS FFR OCT PRE INTERVENTION IVUS vessel size lesion lenght FFR Severity lesion POST INTERVENTION ExpansionAppositionCoverageComplication Underexpansion Edge problems IVUS OCT INDICATION Immediatelly after stent implantation 1 Year after DES Implantation Implantation 1 Year after BMS Implantation Implantation Delayed healing; new intimal growth

Thank you for your attention For any correspondence: For these and further slides on these topics feel free to visit the metcardio.org website: